Association of HLA alleles with non-Hodgkin's lymphoma in Korean population

International Journal of Hematology

Volumn 87, Issue 2, 2008, Pages 203-209

  Choi, Hee Baeg ^a   Roh, Sang Young ^a   Choi, Eun Jung ^a   Yoon, Ho Yeul ^a   Kim, Su Yeon ^a   Hong, Young Sun ^a   Kim, Dong Wook ^a   Kim, Tai Gyu ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

HLA; Non Hodgkin's lymphomas; Polymorphism

Indexed keywords

HLA ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; HLA SYSTEM; HUMAN; KOREA; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; HAPLOTYPES; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; KOREA; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED;

EID: 42049117594     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-008-0040-4     Document Type: Article

References (20)

1. Frizzera G. Non-Hodgkin lymphomas: pathologic features and clinical correlations. In: Hoffman R, (eds) Hematology, basic principles and practice. New York: Churchill Livingstone; 1995.
2. Weiss LM, Movahed LA, Warnke RA, Sklar J. Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease. N Engl J Med. 1989;320:502-6.
3. Lyter DW, Bryant J, Thackeray R, Rinaldo CR, Kingsley LA. Incidence of human immune-deficiency virus-related and non-related malignancies. J Clin Oncol. 1995;13:2540-6.
4. Schlegelberger B, Feller A, Godde E, Grote W, Lennert K. Stepwise development of chromosomal abnormalities in angioimmunoblastic lymphadenopathy. Cancer Genet Cytogenet. 1990;50:15-29.
5. Fogdell A, Hillert J, Sachs C, Olerup O. The multiple sclerosis and nacrolepsy associated HLA class II haplotype includes the DRB5*0101 allele. Tissue Antigens. 1995;46:333-6.
6. Bateman AC, Howell WM. Human leukocyte antigens and cancer: is it in our genes? J Pathol. 1999;188:231-6.
7. Sadler AM, Petronzelli F, Krausa P, et al. Low-resolution DNA typing for HLA-B using sequence-specific primers in allele- or group-specific ARMS/PCR. Tissue Antigens. 1994;44:148-54.
8. Krausa P, Moses J, Bodmer W, Bodmer J, Browning M. HLA-A locus alleles identified by sequence specific PCR. Lancet. 1993;341:121-2.
9. Bunce M, Welsh KI. Rapid DNA typing for HLA-C using sequence-specific primers (PCR-SSP): identification of serological and non-serologically defined HLA-C alleles including several new alleles. Tissue Antigens. 1994;43:7-17.
10. Jordan F, McWhinnie AJ, Turner S, et al. Comparison of HLA-DRB1 typing by DNA-RFLP, PCR-SSO and PCR-SSP methods and their application in providing matched unrelated donors for bone marrow transplantation. Tissue Antigens. 1995;45:103-10.
11. Woolf B. On estimating the relation between blood group and disease. Ann Hum Genet. 1955;19:251-3.
12. Mattiuz PL, Ihde D, Piazza A, Ceppellini R, Bodmer WF. New approaches to the population genetic and segregation analysis of the HLA-A system. In: Terasaki PI, (eds) Histocompatibility testing. Copenhagen: Munksgaard; 1970.
13. Bodmer JG, Tonks S, Oza AM, Mikata A, Takenouchi T, Lister TA, collaborating centers. Hodgkin's disease study. In: HLA 1991. vol 1. Oxford: Oxford University Press; 1992. p. 701-9.
14. Juszczynski P, Kalinka E, Bienvenu J, et al. Human leukocyte antigens class II and tumor necrosis factor genetic polymorphisms are independent predictors of non-Hodgkin lymphoma outcome. Blood. 2002;100:3037-40.
15. Nathalang O, Tatsumi N, Hino M, et al. A preliminary study of HLA-class II alleles in Thai patients with non-Hodgkin's lymphoma. Osaka City Med J. 1997;43:253-8.
16. Al-Tonbary Y, Abdel-Razek N, Zaghloul H, Metwaly S, El-Deek B, El-Shawaf R. HLA class II polymorphism in Egyptian children with lymphomas. Hematology. 2004;9:139-45.
17. Nowak J, Kalinka-Warzocha E, Juszczynski P, Bilinski P, Mika-Witkowska R, Zajko M, Bienvenu J, Coiffier B, Salles G, Warzocha K. Association of human leukocyte antigen ancestral haplotype 8.1 with adverse outcome of non-Hodgkin's lymphoma. Genes Chromosomes Cancer. 2007;46:500-7.
18. Woda BA, Racklin B, Rappaport H. Altered expression of histocompatibility antigens on B large cell lymphomas. Blood. 1981;57:802-4.
19. Diepstra A, Niens M, Vellenga E, van Imhoff GW, Nolte IM, Schaapveld M, van der Steege G, van den Berg A, Kibbelaar RE, te Meerman GJ, Poppema S. Association with HLA class I in Epstein-Barr-virus-positive and with HLA class III in Epstein-Barr-virus-negative Hodgkin's lymphoma. Lancet. 2005;365:2216-24.
20. Imreh MP, Zhang QJ, de Campos-Lima PO, et al. Mechanisms of allele-selective down-regulation of HLA class I in Burkitt's lymphoma. Int J Cancer. 1995;62:90-6.